News Sentiment

ABT sentiment intelligence

Abbott Laboratories news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 58 Balanced news tone 62 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 93.93 Week of 10 Jul 2026
Weighted tone 58/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Earnings

78/100 classification confidence.

Company focus 52

directly relevant articles

Source quality 9

high-authority source matches

Trend context Trend inactive

-1.5% over one week, +6.5% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Abbott Laboratories (ABT) Could Be 15% Undervalued On Raised 2026 Earnings Outlook

Market Reaction

Balanced read

67/100 confidence

News tone and price action are not far from neutral.

Primary event Earnings 78/100 classification
One-week reaction -1.5% Price digesting
Trend fit Trend inactive 6.5% over four weeks
Fair value -15.5% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 22
Neutral 38
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 52
Industry context 10
Sector context 0

Sources

Coverage mix

Publishers
Market source 16
TradingView 4
Seeking Alpha 3
simplywall.st 2
GuruFocus 2
Investor's Business Daily 2
ad-hoc-news.de 2
StockStory 2

Event Lens

What the news is about

Classified themes
Earnings 34
Market update 16
Analyst action 3
Guidance 2
Regulatory and legal 2
Macro sensitivity 2
Balance sheet 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 62
Motley Fool Direct company coverage

Why Abbott Stock Jumped Today

Tone
Neutral 50/100
Event
Market update
Published
17 Jul 2026 02:40
Source
Motley Fool
Morningstar Research Direct company coverage

Analyst Report: Abbott Laboratories

Tone
Neutral 50/100
Event
Analyst action
Published
16 Jul 2026 22:35
Source
Morningstar Research
GuruFocus Direct company coverage

Abbott (ABT) Shares Rise 10.7%

Tone
Neutral 50/100
Event
Market update
Published
16 Jul 2026 21:45
Source
GuruFocus
Barron's Direct company coverage

Abbott Stock Is Leading the S&P 500 After Earnings for Its Best Day in 24 Years

Abbott Laboratories' stock saw its best day in 24 years, leading the S&P 500 after reporting better-than-expected earnings for its second quarter. The company also raised its full-year profit outlook, driven by improved sales in its nutrition segment.

Tone
Positive 93/100
Event
Earnings
Published
16 Jul 2026 18:36
Source
Barron's
Market source Direct company coverage

Abbott Laboratories shares jump as earnings beat estimates and company raises 2026 outlook

Abbott Laboratories (NYSE:ABT) saw its shares rise by nearly 11% after reporting strong second-quarter 2026 results that surpassed Wall Street expectations, with adjusted diluted EPS of $1.31 and revenue of $12.59 billion. The company raised its full-year adjusted diluted EPS gui

Tone
Positive 71/100
Event
Earnings
Published
16 Jul 2026 16:23
Source
Market source
Investor's Business Daily Direct company coverage

Abbott, Up 14%, Strikes Three-Month High After Boosting 2026 Profit Outlook

Abbott stock surged to a three-month high after the company raised its full-year earnings outlook for 2026. This positive revision follows a strong second-quarter report. The new guidance indicates an adjusted earnings per share of $5.45 to $5.60, an increase of about 4 cents at

Tone
Positive 74/100
Event
Earnings
Published
16 Jul 2026 14:10
Source
Investor's Business Daily
Trefis Direct company coverage

Why Abbott Stock Is Reimagining Its Future

Abbott (ABT) is undergoing a significant strategic shift, moving its focus and capital allocation away from its volatile Nutrition segment towards high-margin, innovation-led MedTech and specialized diagnostics. This pivot involves stabilizing the Nutrition segment's margins thro

Tone
Positive 67/100
Event
Market update
Published
16 Jul 2026 14:06
Source
Trefis
Market source Direct company coverage

Is Abbott Laboratories (ABT) Below Fair Value After Its 31% Fall?

Abbott Laboratories (ABT) has experienced a 31% stock price fall over the past year, leading to investor sentiment turning negative. However, both discounted cash flow (DCF) analysis and traditional market multiples suggest the shares are currently trading at a discount. Despite

Tone
Positive 70/100
Event
Balance sheet
Published
16 Jul 2026 13:12
Source
Market source
WSJ Direct company coverage

Abbott Laboratories Sales Rise on Diagnostics Growth

Abbott Laboratories reported higher revenue in the second quarter, primarily driven by increased sales in its diagnostics business. Despite the revenue boost, the company's profit for the quarter fell to $928 million from $1.78 billion in the prior year. Abbott also raised its fu

Tone
Positive 71/100
Event
Earnings
Published
16 Jul 2026 12:36
Source
WSJ
Bloomberg.com Direct company coverage

Abbott Boosts 2026 Profit Guidance as Sales Across Business Rise

Abbott Laboratories has increased its 2026 profit guidance following a better-than-expected second quarter. The company now anticipates adjusted earnings per share to be between $5.45 and $5.60, representing a 5-cent improvement at the midpoint. This positive outlook is attribute

Tone
Positive 81/100
Event
Earnings
Published
16 Jul 2026 11:42
Source
Bloomberg.com
PR Newswire Direct company coverage

Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance

Abbott announced its second-quarter 2026 financial results, reporting a 13.0% increase in sales and a 4.8% comparable sales growth. The company also raised its full-year 2026 adjusted diluted EPS guidance to $5.45 to $5.60, up from the previous range of $5.38 to $5.58. Key busine

Tone
Positive 73/100
Event
Earnings
Published
16 Jul 2026 11:29
Source
PR Newswire
Courthouse News Direct company coverage

Employees sue medical giant over excessive healthcare costs

A group of Abbott Laboratories employees has filed a class-action lawsuit alleging they were overcharged for health insurance plans that offered no additional benefits. The suit claims Abbott offered two plans with the same medical coverage but different costs, violating the Empl

Tone
Negative 30/100
Event
Regulatory and legal
Published
15 Jul 2026 17:35
Source
Courthouse News
TradingView Direct company coverage

Reasons to Retain Abbott Stock in Your Portfolio for Now

Abbott Laboratories (ABT) is recommended as a stock to retain due to strong performance in its Nutrition business and growth in emerging markets within its Established Pharmaceuticals Division (EPD). However, potential headwinds include currency fluctuations, a dull macroeconomic

Tone
Positive 64/100
Event
Macro sensitivity
Published
15 Jul 2026 15:37
Source
TradingView